Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease.

Akbari M, Shah S, Velayos FS, Mahadevan U, Cheifetz AS.

Inflamm Bowel Dis. 2013 Jan;19(1):15-22. doi: 10.1002/ibd.22948. Review.

PMID:
22434610
2.

Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines.

Teruel C, López-San Román A, Bermejo F, Taxonera C, Pérez-Calle JL, Gisbert JP, Martín-Arranz M, Ponferrada A, Van Domselaar M, Algaba A, Estellés J, López-Serrano P, Linares PM, Muriel A.

Am J Gastroenterol. 2010 Sep;105(9):2003-8. doi: 10.1038/ajg.2010.138. Epub 2010 Aug 10.

PMID:
20700117
3.

The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy.

Hutson JR, Matlow JN, Moretti ME, Koren G.

J Obstet Gynaecol. 2013 Jan;33(1):1-8. doi: 10.3109/01443615.2012.716106. Review.

PMID:
23259868
5.

The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD).

Shim L, Eslick GD, Simring AA, Murray H, Weltman MD.

J Crohns Colitis. 2011 Jun;5(3):234-8. doi: 10.1016/j.crohns.2011.01.009. Epub 2011 Feb 22.

PMID:
21575887
6.

Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study.

Langagergaard V, Pedersen L, Gislum M, Nørgard B, Sørensen HT.

Aliment Pharmacol Ther. 2007 Jan 1;25(1):73-81.

7.

Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.

Coelho J, Beaugerie L, Colombel JF, Hébuterne X, Lerebours E, Lémann M, Baumer P, Cosnes J, Bourreille A, Gendre JP, Seksik P, Blain A, Metman EH, Nisard A, Cadiot G, Veyrac M, Coffin B, Dray X, Carrat F, Marteau P; CESAME Pregnancy Study Group (France).

Gut. 2011 Feb;60(2):198-203. doi: 10.1136/gut.2010.222893. Epub 2010 Nov 29.

PMID:
21115547
8.

Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis.

Mozaffari S, Abdolghaffari AH, Nikfar S, Abdollahi M.

Hum Exp Toxicol. 2015 May;34(5):445-59. doi: 10.1177/0960327114550882. Epub 2014 Nov 5.

PMID:
25378092
9.

Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease.

Jharap B, de Boer NK, Stokkers P, Hommes DW, Oldenburg B, Dijkstra G, van der Woude CJ, de Jong DJ, Mulder CJ, van Elburg RM, van Bodegraven AA; Dutch Initiative on Crohn and Colitis.

Gut. 2014 Mar;63(3):451-7. doi: 10.1136/gutjnl-2012-303615. Epub 2013 Feb 19.

PMID:
23424097
10.

Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.

Kotlyar DS, Lewis JD, Beaugerie L, Tierney A, Brensinger CM, Gisbert JP, Loftus EV Jr, Peyrin-Biroulet L, Blonski WC, Van Domselaar M, Chaparro M, Sandilya S, Bewtra M, Beigel F, Biancone L, Lichtenstein GR.

Clin Gastroenterol Hepatol. 2015 May;13(5):847-58.e4; quiz e48-50. doi: 10.1016/j.cgh.2014.05.015. Epub 2014 May 28.

PMID:
24879926
11.

T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.

Deepak P, Sifuentes H, Sherid M, Stobaugh D, Sadozai Y, Ehrenpreis ED.

Am J Gastroenterol. 2013 Jan;108(1):99-105. doi: 10.1038/ajg.2012.334. Epub 2012 Oct 2.

PMID:
23032984
12.

Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease.

Casanova MJ, Chaparro M, Domènech E, Barreiro-de Acosta M, Bermejo F, Iglesias E, Gomollón F, Rodrigo L, Calvet X, Esteve M, García-Planella E, García-López S, Taxonera C, Calvo M, López M, Ginard D, Gómez-García M, Garrido E, Pérez-Calle JL, Beltrán B, Piqueras M, Saro C, Botella B, Dueñas C, Ponferrada A, Mañosa M, García-Sánchez V, Maté J, Gisbert JP.

Am J Gastroenterol. 2013 Mar;108(3):433-40. doi: 10.1038/ajg.2012.430. Epub 2013 Jan 15.

PMID:
23318480
13.

Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis.

Rahimi R, Nikfar S, Rezaie A, Abdollahi M.

Reprod Toxicol. 2008 Feb;25(2):271-5. doi: 10.1016/j.reprotox.2007.11.010. Epub 2007 Dec 4.

PMID:
18242053
14.

Azathioprine, mercaptopurine and birth outcome: a population-based cohort study.

Nørgård B, Pedersen L, Fonager K, Rasmussen SN, Sørensen HT.

Aliment Pharmacol Ther. 2003 Mar 15;17(6):827-34.

15.

Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.

Ban L, Tata LJ, Fiaschi L, Card T.

Gastroenterology. 2014 Jan;146(1):76-84. doi: 10.1053/j.gastro.2013.09.061. Epub 2013 Oct 12.

PMID:
24126096
16.

The risk of congenital abnormalities in children fathered by men treated with azathioprine or mercaptopurine before conception.

Nørgård B, Pedersen L, Jacobsen J, Rasmussen SN, Sørensen HT.

Aliment Pharmacol Ther. 2004 Mar 15;19(6):679-85.

17.

Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain.

Gómez-García M, Cabello-Tapia MJ, Sánchez-Capilla AD, De Teresa-Galván J, Redondo-Cerezo E.

World J Gastroenterol. 2013 Aug 14;19(30):4877-86. doi: 10.3748/wjg.v19.i30.4877.

18.

Anti-Tumour Necrosis Factor α Therapies and Inflammatory Bowel Disease Pregnancy Outcomes: A Meta-analysis.

Shihab Z, Yeomans ND, De Cruz P.

J Crohns Colitis. 2016 Aug;10(8):979-88. doi: 10.1093/ecco-jcc/jjv234. Epub 2016 Jan 11. Review.

PMID:
26755733
19.

Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: a cohort study.

Setshedi M, Epstein D, Winter TA, Myer L, Watermeyer G, Hift R.

J Gastroenterol Hepatol. 2012 Feb;27(2):385-9. doi: 10.1111/j.1440-1746.2011.06865.x.

PMID:
21793904
20.

Use of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: a meta-analysis.

Gong J, Zhu L, Guo Z, Li Y, Zhu W, Li N, Li J.

PLoS One. 2013 Nov 28;8(11):e81487. doi: 10.1371/journal.pone.0081487. eCollection 2013.

Supplemental Content

Support Center